(IONQ) IONQ - Overview
Stock: Quantum Computers, Cloud Access, Quantum Networks, Consulting Services
| Risk 5d forecast | |
|---|---|
| Volatility | 110% |
| Relative Tail Risk | -6.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | -50.90 |
| Character TTM | |
|---|---|
| Beta | 2.554 |
| Beta Downside | 2.272 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.92% |
| CAGR/Max DD | 1.42 |
Description: IONQ IONQ December 17, 2025
IonQ, Inc. (NYSE: IONQ) designs, builds, and operates quantum-computing hardware in the United States, monetizing the technology primarily through a cloud-based access model. Customers can run quantum workloads via major platforms such as Amazon Braket, Microsoft Azure Quantum, and Google Cloud Marketplace, as well as directly through IonQ’s own portal.
The firm also offers quantum-safe networking products-including quantum key-distribution (QKD) systems, quantum random-number generators, and single-photon detectors-and provides professional services ranging from hardware design contracts to algorithm co-development consulting. A notable partnership with AstraZeneca aims to accelerate computational chemistry for drug discovery and materials science.
Key recent metrics: Q2 2024 revenue reached $12.4 million, a 38 % YoY increase driven by higher cloud-usage fees; the company’s cash runway extends through Q4 2025 at current burn rates; and its latest 32-qubit trapped-ion processor achieved a quantum-volume of 2,048, positioning IonQ among the top performers in the trapped-ion segment. The broader quantum-computing market is projected to grow at a CAGR of roughly 30 % through 2030, fueled by expanding government R&D budgets and corporate demand for quantum-enhanced optimization and simulation.
For a deeper, data-driven assessment of IONQ’s valuation metrics, you may find the ValueRay platform useful.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income: -1.47b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.06 > 0.02 and ΔFCF/TA 18.09 > 1.0 |
| NWC/Revenue: 1348 % < 20% (prev 969.0%; Δ 378.8% < -1%) |
| CFO/TA -0.06 > 3% & CFO -248.1m > Net Income -1.47b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 8.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (294.5m) vs 12m ago 37.43% < -2% |
| Gross Margin: 23.47% > 18% (prev 0.29%; Δ 2317 % > 0.5%) |
| Asset Turnover: 3.31% > 50% (prev 7.53%; Δ -4.21% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
Altman Z'' -5.00
| A: 0.25 (Total Current Assets 1.22b - Total Current Liabilities 139.3m) / Total Assets 4.32b |
| B: -0.45 (Retained Earnings -1.95b / Total Assets 4.32b) |
| C: -0.62 (EBIT TTM -1.49b / Avg Total Assets 2.41b) |
| D: -0.97 (Book Value of Equity -1.96b / Total Liabilities 2.03b) |
| Altman-Z'' Score: -5.00 = D |
Beneish M 1.00
| DSRI: 0.25 (Receivables 36.9m/70.3m, Revenue 79.8m/37.5m) |
| GMI: 1.24 (GM 23.47% / 29.21%) |
| AQI: 7.94 (AQ_t 0.69 / AQ_t-1 0.09) |
| SGI: 2.13 (Revenue 79.8m / 37.5m) |
| TATA: -0.28 (NI -1.47b - CFO -248.1m) / TA 4.32b) |
| Beneish M-Score: 1.21 (Cap -4..+1) = D |
What is the price of IONQ shares?
Over the past week, the price has changed by -12.48%, over one month by -31.07%, over three months by -39.07% and over the past year by -15.22%.
Is IONQ a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IONQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 75.2 | 114.8% |
| Analysts Target Price | 75.2 | 114.8% |
| ValueRay Target Price | 44.3 | 26.7% |
IONQ Fundamental Data Overview January 31, 2026
P/B = 7.1375
Revenue TTM = 79.8m USD
EBIT TTM = -1.49b USD
EBITDA TTM = -1.45b USD
Long Term Debt = 28.5m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 8.60m USD (from shortTermDebt, last quarter)
Debt = 28.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -317.5m USD (from netDebt column, last quarter)
Enterprise Value = 15.03b USD (16.08b + Debt 28.5m - CCE 1.08b)
Interest Coverage Ratio = unknown (Ebit TTM -1.49b / Interest Expense TTM 0.0)
EV/FCF = -57.19x (Enterprise Value 15.03b / FCF TTM -262.8m)
FCF Yield = -1.75% (FCF TTM -262.8m / Enterprise Value 15.03b)
FCF Margin = -329.2% (FCF TTM -262.8m / Revenue TTM 79.8m)
Net Margin = -1836 % (Net Income TTM -1.47b / Revenue TTM 79.8m)
Gross Margin = 23.47% ((Revenue TTM 79.8m - Cost of Revenue TTM 61.1m) / Revenue TTM)
Gross Margin QoQ = 47.99% (prev 8.46%)
Tobins Q-Ratio = 3.48 (Enterprise Value 15.03b / Total Assets 4.32b)
Interest Expense / Debt = 2.40% (Interest Expense 685.0k / Debt 28.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -1.17b (EBIT -1.49b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 8.73 (Total Current Assets 1.22b / Total Current Liabilities 139.3m)
Debt / Equity = 0.01 (Debt 28.5m / totalStockholderEquity, last quarter 2.27b)
Debt / EBITDA = 0.22 (negative EBITDA) (Net Debt -317.5m / EBITDA -1.45b)
Debt / FCF = 1.21 (negative FCF - burning cash) (Net Debt -317.5m / FCF TTM -262.8m)
Total Stockholder Equity = 1.15b (last 4 quarters mean from totalStockholderEquity)
RoA = -60.87% (Net Income -1.47b / Total Assets 4.32b)
RoE = -127.9% (Net Income TTM -1.47b / Total Stockholder Equity 1.15b)
RoCE = -126.6% (out of range, set to none) (EBIT -1.49b / Capital Employed (Equity 1.15b + L.T.Debt 28.5m))
RoIC = -102.5% (out of range, set to none) (NOPAT -1.17b / Invested Capital 1.15b)
WACC = 15.31% (E(16.08b)/V(16.11b) * Re(15.33%) + D(28.5m)/V(16.11b) * Rd(2.40%) * (1-Tc(0.21)))
Discount Rate = 15.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 19.77%
Fair Price DCF = unknown (Cash Flow -262.8m)
EPS Correlation: -64.48 | EPS CAGR: -4.76% | SUE: 1.66 | # QB: 1
Revenue Correlation: 94.37 | Revenue CAGR: 133.9% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-03-31): EPS=-0.50 | Chg30d=-0.031 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=-1.80 | Chg30d=+0.042 | Revisions Net=-1 | Growth EPS=+65.0% | Growth Revenue=+76.4%